Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Chromos Molecular Systems acquires Targeted Molecules Corporation

Fasken
Reading Time 1 minute read Subscribe
Client

Chromos Molecular Systems

On February 2, 2006, Chromos Molecular Systems Inc. announced that it had acquired Targeted Molecules Corporation, a privately held biotechnology company based in San Diego, CA. With the acquisition, Chromos gained two antibody product candidates for treatment of multiple sclerosis and acute thrombosis. Chromos was advised by a team from Fasken Martineau comprised of Iain Mant, Sonya Reiss and Deepak Gill.

    Subscribe

    Receive email updates from our team

    Subscribe